Your browser is no longer supported. Please, upgrade your browser.
Protara Therapeutics, Inc.
Index- P/E- EPS (ttm)-4.47 Insider Own0.10% Shs Outstand11.23M Perf Week-5.37%
Market Cap90.40M Forward P/E- EPS next Y-4.29 Insider Trans- Shs Float9.09M Perf Month-18.58%
Income-37.40M PEG- EPS next Q-1.05 Inst Own79.20% Short Float2.09% Perf Quarter-29.13%
Sales- P/S- EPS this Y84.40% Inst Trans- Short Ratio1.75 Perf Half Y-55.90%
Book/sh16.76 P/B0.47 EPS next Y0.00% ROA-22.70% Target Price- Perf Year-69.24%
Cash/sh7.39 P/C1.07 EPS next 5Y- ROE-23.30% 52W Range7.52 - 27.55 Perf YTD-67.24%
Dividend- P/FCF- EPS past 5Y38.20% ROI- 52W High-71.21% Beta0.67
Dividend %- Quick Ratio26.50 Sales past 5Y- Gross Margin- 52W Low5.45% ATR0.48
Employees27 Current Ratio26.50 Sales Q/Q- Oper. Margin- RSI (14)35.65 Volatility6.14% 5.57%
OptionableYes Debt/Eq0.00 EPS Q/Q33.70% Profit Margin- Rel Volume0.22 Prev Close8.05
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume108.74K Price7.93
Recom1.40 SMA20-7.40% SMA50-15.21% SMA200-51.04% Volume23,927 Change-1.49%
Jun-04-21Initiated H.C. Wainwright Buy $40
Feb-17-21Initiated Oppenheimer Outperform $43
Oct-19-20Initiated Cowen Outperform $50
Jul-29-20Initiated Guggenheim Buy $50
Jul-07-21 08:00AM  
Jun-22-21 07:30AM  
Jun-10-21 08:00AM  
May-13-21 08:00AM  
May-06-21 07:30AM  
Apr-23-21 07:00AM  
Apr-19-21 04:09PM  
Apr-12-21 11:12AM  
Mar-30-21 07:01AM  
Mar-11-21 07:30AM  
Mar-10-21 08:00AM  
Feb-04-21 08:00AM  
Feb-02-21 08:00AM  
Dec-16-20 11:07PM  
Dec-07-20 04:30PM  
Dec-03-20 07:00AM  
Nov-24-20 07:00AM  
Nov-12-20 07:15AM  
Nov-11-20 07:00AM  
Nov-04-20 07:00AM  
Sep-28-20 03:12PM  
Sep-22-20 08:13AM  
Sep-21-20 04:01PM  
Sep-08-20 07:00AM  
Sep-02-20 05:49PM  
Aug-03-20 07:00AM  
Jul-28-20 07:00AM  
Jul-24-20 07:00AM  
Jul-03-20 06:34PM  
Jul-02-20 07:59PM  
Jun-02-20 04:05PM  
May-26-20 08:30AM  
May-13-20 08:00AM  
May-11-20 08:38AM  
May-05-20 04:05PM  
Apr-02-20 07:00AM  
Feb-11-20 08:00AM  
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Olivo Martin SebastianChief Medical OfficerJun 10Buy10.109,89399,96814,344Jun 14 05:52 PM
Opaleye Management Inc.10% OwnerSep 30Buy16.0050,000800,0002,458,472Oct 02 06:05 AM
Opaleye Management Inc.10% OwnerSep 24Buy16.87300,0005,061,0002,408,472Sep 25 05:15 PM
Davis BlaineChief Financial OfficerSep 22Buy16.911,48125,0381,481Sep 23 09:20 AM
Marshall RandallFormer 10% OwnerSep 14Sale19.402,55449,541585,600Sep 15 06:04 PM
Marshall Randall10% OwnerSep 10Sale18.002394,302588,154Sep 14 04:37 PM
Marshall Randall10% OwnerSep 09Sale18.6610,222190,766588,393Sep 10 03:58 PM
Marshall Randall10% OwnerSep 08Sale18.943,10858,866598,615Sep 10 03:58 PM
Marshall Randall10% OwnerSep 03Sale20.19521,050601,723Sep 04 04:39 PM
Marshall Randall10% OwnerSep 02Sale20.682074,281601,775Sep 04 04:39 PM
Marshall Randall10% OwnerAug 28Sale22.0977117,031601,982Sep 01 04:53 PM
Marshall Randall10% OwnerAug 27Sale22.3761613,780602,753Aug 28 03:56 PM
Marshall Randall10% OwnerAug 26Sale22.401,41831,763603,369Aug 28 03:56 PM
Marshall Randall10% OwnerAug 25Sale22.732,46155,939604,787Aug 26 04:27 PM
Marshall Randall10% OwnerAug 24Sale23.1697422,558607,248Aug 26 04:27 PM
Marshall Randall10% OwnerAug 20Sale24.1851012,333608,222Aug 24 09:51 AM
Marshall Randall10% OwnerAug 18Sale25.192005,038608,732Aug 20 04:18 PM
Marshall Randall10% OwnerAug 17Sale25.111,54838,870608,932Aug 18 05:48 PM
Marshall Randall10% OwnerAug 14Sale25.0970017,563610,480Aug 18 05:48 PM